WallStreetZenWallStreetZen

NASDAQ: CRMD
Cormedix Inc Stock

$4.24+0.08 (+1.92%)
Updated Mar 28, 2024
CRMD Price
$4.24
Fair Value Price
$1.05
Market Cap
$233.12M
52 Week Low
$2.57
52 Week High
$6.09
P/E
-4.66x
P/B
3.32x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$46.34M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.17
Operating Cash Flow
-$38M
Beta
1.33
Next Earnings
May 13, 2024
Ex-Dividend
N/A
Next Dividend
N/A

CRMD Overview

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Zen Score

–
Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CRMD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CRMD ($4.24) is overvalued by 302.99% relative to our estimate of its Fair Value price of $1.05 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CRMD ($4.24) is not significantly undervalued (302.99%) relative to our estimate of its Fair Value price of $1.05 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CRMD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CRMD due diligence checks available for Premium users.

Be the first to know about important CRMD news, forecast changes, insider trades & much more!

Valuation

CRMD fair value

Fair Value of CRMD stock based on Discounted Cash Flow (DCF)
Price
$4.24
Fair Value
$1.05
Overvalued by
302.99%
CRMD ($4.24) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CRMD ($4.24) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CRMD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CRMD price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-4.66x
Industry
14.26x
Market
44.51x

CRMD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.32x
Industry
6.21x
CRMD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CRMD's financial health

Profit margin

Revenue
$0.0
Net Income
-$14.8M
Profit Margin
0%
CRMD's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$82.1M
Liabilities
$11.9M
Debt to equity
0.17
CRMD's short-term assets ($79.45M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CRMD's short-term assets ($79.45M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CRMD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CRMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$10.7M
Investing
$597.8k
Financing
$467.7k
CRMD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CRMD vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
CRMD$233.12M+1.92%-4.66x3.32x
XFOR$233.43M-1.42%-2.44x4.57x
FGEN$232.11M-8.91%-0.80x-1.14x
IPHA$231.89M+21.01%-29.39x4.11x
VNDA$236.48M+5.66%102.75x0.43x

Cormedix Stock FAQ

What is Cormedix's quote symbol?

(NASDAQ: CRMD) Cormedix trades on the NASDAQ under the ticker symbol CRMD. Cormedix stock quotes can also be displayed as NASDAQ: CRMD.

If you're new to stock investing, here's how to buy Cormedix stock.

What is the 52 week high and low for Cormedix (NASDAQ: CRMD)?

(NASDAQ: CRMD) Cormedix's 52-week high was $6.09, and its 52-week low was $2.57. It is currently -30.38% from its 52-week high and 64.98% from its 52-week low.

How much is Cormedix stock worth today?

(NASDAQ: CRMD) Cormedix currently has 54,981,102 outstanding shares. With Cormedix stock trading at $4.24 per share, the total value of Cormedix stock (market capitalization) is $233.12M.

Cormedix stock was originally listed at a price of $15.00 in May 13, 2010. If you had invested in Cormedix stock at $15.00, your return over the last 13 years would have been -71.73%, for an annualized return of -9.26% (not including any dividends or dividend reinvestments).

How much is Cormedix's stock price per share?

(NASDAQ: CRMD) Cormedix stock price per share is $4.24 today (as of Mar 28, 2024).

What is Cormedix's Market Cap?

(NASDAQ: CRMD) Cormedix's market cap is $233.12M, as of Mar 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Cormedix's market cap is calculated by multiplying CRMD's current stock price of $4.24 by CRMD's total outstanding shares of 54,981,102.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.